Anna G. Afinogenova

Anna G. Afinogenova

Auto-generated profile, based on publicly available information

Anna G. Afinogenova

Saint Petersburg Pasteur Institute

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2020 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
PDF file
АMА. A. Meleshko
А. A. Meleshko
AAA. G. Afinogenova
A. G. Afinogenova
GAG. E. Afinogenov
G. E. Afinogenov
ASA. A. Spiridonova
A. A. Spiridonova
VTValeri P. Tolstoy
Valeri P. Tolstoy
Metal and metal oxide nanoparticles (NPs) are promising antibacterial agents. They have a broad antimicrobial activity against both Gram-positive and Gram-negative bacteria, viruses, and protozoans. The use of NPs reduces the possibility of the microbial resistance development. This review briefly shows the general mechanisms and the main factors of antibacterial activity of NPs. In this article, a comprehensive review of the recent researches in the field of new antimicrobial agents with superior long-term bactericidal activity and low toxicity is provided. The review gives the examples of synthesis of double and triple nanocomposites based on following oxides: CuO, ZnO, Fe3O4, Ag2O, MnO2, etc. including metal and nonmetal doped nanocomposites (for example with Ag, Ce, Cr, Mn, Nd, Co, Sn, Fe, N, F, etc.). Compared with bactericidal action of individual oxides, the nanocomposites demonstrate superior antibacterial activity and have synergistic effects. For example, the antimicrobial activity of ZnO against both Gram-positive and Gram-negative bacteria was increased by -100% by formation of triple nanocomposites ZnO—MnO2—Cu2O or ZnO—Ag2O—Ag2S. Similar effect was showed for Ce-doped ZnO and Zn-doped CuO. The present article also provides the examples of nanocomposites containing NPs and organic (chitosan, cellulose, polyvinylpyrrolidone, biopolymers, etc.) or inorganic materials with special structure (graphene oxide, TiO2 nanotubes, silica) which demonstrate controlled release and longterm antibacterial activity. All of the considered nanocomposites and their combinations have a pronounced long-term antimicrobial effect including against antibiotic-resistant strains. They are able to prevent the formation of microbial biofilms on biotic and abiotic surfaces, have low toxicity to eukaryotic cells, demonstrate anti-inflammatory and woundhealing properties in compositions with polymers (sodium alginate, collagen, polyvinylpyrrolidone, etc.). The use of nanoscale systems can solve several important practical problems at the same time: saving of long-term antimicrobial activities while reducing the number of compounds, creation of new antimicrobial agents with low toxicity and reduced environmental impact, development of new biocidal materials, including new coatings for effective antimicrobial protection of medical devices.

14 January 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MZMaria Zharkova
Maria Zharkova
AKAleksey S. Komlev
Aleksey S. Komlev
TFTatiana A. Filatenkova
Tatiana A. Filatenkova
MSMaria S. Sukhareva
Maria S. Sukhareva
EVElizaveta V. Vladimirova
Elizaveta V. Vladimirova
Olga ShamovaOlga Shamova
Olga Shamova
Antimicrobial peptides (AMPs) are acknowledged as a promising template for designing new antimicrobials. At the same time, existing toxicity issues and limitations in their pharmacokinetics make topical application one of the less complicated routes to put AMPs-based therapeutics into actual medical practice. Antiseptics are one of the common components for topical treatment potent against antibiotic-resistant pathogens but often with toxicity limitations of their own. Thus, the interaction of AMPs and antiseptics is an interesting topic that is also less explored than combined action of AMPs and antibiotics. Herein, we analyzed antibacterial, antibiofilm, and cytotoxic activity of combinations of both membranolytic and non-membranolytic AMPs with a number of antiseptic agents. Fractional concentration indices were used as a measure of possible effective concentration reduction achievable due to combined application. Cases of both synergistic and antagonistic interaction with certain antiseptics and surfactants were identified, and trends in the occurrence of these types of interaction were discussed. The data may be of use for AMP-based drug development and suggest that the topic requires further attention for successfully integrating AMPs-based products in the context of complex treatment. AMP/antiseptic combinations show promise for creating topical formulations with improved activity, lowered toxicity, and, presumably, decreased chances of inducing bacterial resistance. However, careful assessment is required to avoid AMP neutralization by certain antiseptic classes in either complex drug design or AMP application alongside other therapeutics/care products.

1 July 2020 in Pediatric Traumatology, Orthopaedics and Reconstructive Surgery
Verified
Journal Article
Open access
PDF file
AMAleksandra A. Meleshko
Aleksandra A. Meleshko
VTValeri P. Tolstoy
Valeri P. Tolstoy
GAGennady E. Afinogenov
Gennady E. Afinogenov
ALAleksandra Levshakova
Aleksandra Levshakova
AAAnna G. Afinogenova
Anna G. Afinogenova
SLStanislav A. Linnik
Stanislav A. Linnik
The present brief review focuses on the features of the Layer-by-Layer (LbL) synthesis of coatings containing hydroxyapatite nanoparticles and assesses their use in solving several biomedical problems. This work provides the state-of-art of this field. This method is based on the sequential chemical adsorption of reagents on the substrate surface that makes it possible to apply nanolayers of the specified composition on the surface of a wide range of substrates of complex shape, to control the thickness of the synthesized layers accurately at the nanometer level. It also enables the modification of surface characteristics, including roughness, hydrophilicity, and surface charge, and allows artificially constructed multilayers consisting of hybrid organic and inorganic substances to be obtained. The experimental material presented in the review demonstrates the effectiveness of LbL synthesis for creating new 3D scaffolds as bone substitutes, coatings on the surface of metal implants, and drug delivery systems. A promising direction for the development of LbL synthesis is the creation of methods that involve ion-substituted hydroxyapatites as reagents. Success in this area can pave the way for significant advances in biomedicine and open new opportunities for creating a new generation of structures that mimic the structural, compositional, and mechanical properties of the bone mineral phase.

1 January 2020 in Bulletin of Pirogov National Medical & Surgical Center
Verified
Journal Article
Closed access
AZA.B. Zemlyanoj
A.B. Zemlyanoj
AAA.G. Afinogenova
A.G. Afinogenova
SMS.A. Matveev
S.A. Matveev

1 January 2018 in Medical Immunology (Russia)
Verified
Journal Article
Open access
MZM. S. Zharkova
M. S. Zharkova
PKP. M. Kopeykin
P. M. Kopeykin
GAG. E. Afinogenov
G. E. Afinogenov
DODmitriy Orlov
Dmitriy Orlov
AAA. Yu. Artamonov
A. Yu. Artamonov
Olga ShamovaOlga Shamova
Olga Shamova
Резистентность патогенных микроорганизмов к применяемым в медицине антибиотикам в последние годы стремительно растет, повышается смертность от внутрибольничных инфекций. Поэтому поиск новых лекарственных средств для борьбы с антибиотикоустойчивыми бактериями является одной из первоочередных задач биомедицины. Есть все основания считать, что природные соединения, содержащиеся в защитных клетках человека и животных, могут послужить прототипами принципиально новых антибиотических препаратов. К таким соединениям относятся антимикробные пептиды врожденного иммунитета, в частности группа пролин-богатых пептидов. Целью данной работы явилось исследование антимикробной активности пролин-богатых пептидов семейства бактенецинов в отношении ряда клинических изолятов антибиотикоустойчивых грамотрицательных бактерий. Объектами исследования послужили бактенецины, обнаруженные ранее в лейкоцитах домашней козы Capra hircus: ChBac3.4, ChBac5, miniChBac7.5Nα, miniChBac7.5Nβ. Установлено, что химически синтезированные нами аналоги этих пептидов проявляют выраженную антимикробную активность в отношении Escherichia coli и Acinetobacter baumannii (минимальные ингибирующие концентрации (МИК), определенные методом серийных разведений в жидкой питательной среде, находились в пределах 1-4 мкМ) и в несколько меньшей степени в отношении Pseudomonas aeruginosa и Klebsiella pneumoniae (МИК – 2-16 мкМ) in vitro. Показано, что антибактериальная активность пептидов может повышаться при их совместном использовании с антибиотиками, применяемыми в медицине. Выявлен синергический эффект при действии бактенецина mini-ChBac7.5Nα в комбинации с амикацином на E. coli (минимальный индекс фракционной ингибирующей концентрации (иФИК) – 0,375), A. baumannii (иФИК 0,5) и K. pneumoniae (иФИК – 0,325), а также с офлоксацином – на K. pneumoniae (иФИК – 0,5). Важной характеристикой исследуемых пептидов является отсутствие у этих соединений гемолитической активности в отношении эритроцитов человека при применении их в концентрациях, в несколько раз превышающих антимикробные. Полученные данные свидетельствуют о перспективности дальнейшего исследования рассматриваемых пролин-богатых пептидов и их структурных модификаций для разработки на основе этих соединений новых комбинированных лекарственных средств для борьбы с антибиотикоустойчивыми микроорганизмами: различных препаратов местного применения, компонентов изделий медицинского назначения, в частности венозных катетеров, стентов, а также раневых покрытий.

7 November 2024 in HERALD of North-Western State Medical University named after I.I. Mechnikov
Verified
Journal Article
Closed access
PDF file
SLStanislav A. Linnik
Stanislav A. Linnik
GAGennady E. Afinogenov
Gennady E. Afinogenov
AAAnna G. Afinogenova
Anna G. Afinogenova
IKIvan O. Kucheev
Ivan O. Kucheev
GKGiorgi Karagezov
Giorgi Karagezov
ЦБЦололо Ярослав Борисович
Цололо Ярослав Борисович
BACKGROUND: Surgical treatment of fractures of the proximal femur in elderly patients makes it possible to put patients on their feet early and improve their quality of life. Local purulent complications in the postoperative period after hip fractures surgical treatment occur in 5–10% of cases. AIM: To improve the treatment outcomes of patients with local postoperative purulent complications of soft tissues by a comparative analysis of treatment methods with various antibacterial, antiseptic hydrogels and physical methods of wound treatment. MATERIALS AND METHODS: The article presents the nature of local purulent complications, their clinical picture, and diagnostic features. All the patients are divided into 2 groups. The main group included 53 patients, and the control group included 48. The patients of the main group underwent comprehensive treatment of local purulent complications using modern technologies (plasma scalpel) and dressings with hydrogel Argacol. The control group was treated with traditional bandages with dioxomethyltetrahydropyrimidine and chloramphenicol. RESULTS: The use of surgical wound treatment using a plasma scalpel and dressings with multifunctional hydrogel allows to accelerate the wound healing process by 2–3 weeks compared with the use of traditional techniques. CONCLUSIONS: The application of the proposed tactics of providing specialized care to elderly patients with a fracture of the proximal femur allows for a significant (p 0.05) improvement in treatment results.